Myriad Genetics Inc

MYGN

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000899923

SEC filings (opens in a new tab)

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Myriad Genetics Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of MYGN: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	186	1	194	+9
Shares	82.7M	10	89.9M	+7.20M (+8.7%)
Value	$1.33B	$0	$1.72B	+$394.3M (+29.7%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Myriad Genetics Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to MYGN in Q4 2023
Institution	Shares	Value	% of portfolio
Kent Lake Capital LLC	108,377	$2.07M	0.80%
Voloridge Investment Management, LLC	99,112	$1.90M	0.01%
Caption Management, LLC	57,845	$1.11M	0.12%
Pura Vida Investments, LLC	50,000	$957.0K	1.04%
Monashee Investment Management LLC	50,000	$957.0K	0.17%
Virtu Financial LLC	22,366	$428.0K	0.03%
Cipher Capital LP	16,526	$316.3K	0.10%
Centiva Capital, LP	14,169	$271.2K	0.02%
Clarus Wealth Advisors	10,119	$204.4K	0.12%
EntryPoint Capital, LLC	2,819	$54.0K	0.05%
GAMMA Investing LLC	1,210	$25.9K	0.01%
Tompkins Financial Corp	840	$16.1K	0.00%
Principal Securities, Inc.	476	$9.11K	0.00%
Hexagon Capital Partners LLC	375	$7.18K	0.00%
DAGCO, Inc.	276	$5.28K	0.00%
Dynamic Wealth Strategies, LLC	276	$5.28K	0.00%
Pineridge Advisors LLC	236	$4.52K	0.00%
Washington Trust Co	164	$3.14K	0.00%
Bokf, NA	159	$3.04K	0.00%
Bessemer Group Inc	135	$3.00K	0.00%
Arlington Trust Co LLC	145	$2.77K	0.00%
Steward Partners Investment Advisory, LLC	129	$2.47K	0.00%
Clear Street Markets LLC	100	$2.00K	0.00%
Lindbrook Capital, LLC	103	$1.97K	0.00%
Signaturefd, LLC	60	$1.15K	0.00%
Russell Investments Group, Ltd.	31	$593	0.00%
Tucker Asset Management LLC	12	$230	0.00%
DiNuzzo Private Wealth, Inc.	7	$134	0.00%

Sold out (19)

Institutions that held Myriad Genetics Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of MYGN in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Balyasny Asset Management LLC	290,808	$4.66M
Cubist Systematic Strategies, LLC	130,509	$2.09M
HRT Financial LP	70,472	$1.13M
AMH Equity Ltd	47,285	$758.5K
Edgestream Partners, L.P.	39,855	$639.3K
Point72 Middle East FZE	25,120	$402.9K
ExodusPoint Capital Management, LP	17,960	$288.0K
Blair William & Co	11,866	$190.3K
GTS Securities LLC	11,779	$188.9K
Vontobel Holding Ltd.	11,660	$187.0K
E Fund Management Co., Ltd.	10,709	$172.0K
Traverso Chambers Private Wealth Management, LLC	10,357	$166.1K
Aquatic Capital Management LLC	5,200	$83.0K
Group One Trading, L.P.	4,055	$65.0K
Point72 Asset Management, L.P.	2,636	$42.3K
Park Place Capital Corp	1,366	$21.9K
Huntington National Bank	199	$3.19K
Assetmark, Inc	182	$2.92K
Global Retirement Partners, LLC	18	$282

Not filed for Q4 2023 yet (1)

Institutions that held Myriad Genetics Inc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MYGN in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Steward Financial Group LLC	10	$0